| Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively (NCT01868243) | Hospital Ana Nery | 2013-08-01 |
| A Study of Anlotinib in Subjects With Advanced Malignancy (NCT04216082) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2013-08-01 |
| Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis (NCT01938599) | AmDerma | 2013-08-01 |
| TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) (NCT01970215) | Xention Ltd | 2013-08-01 |
| Dysport for the Treatment of OMD (NCT01921270) | Emory University | 2013-08-01 |
| Upregulation of Alpha-1 Receptors Upon Septic Shock? (NCT01856517) | Direction Centrale du Service de Santé des Armées | 2013-08-01 |
| RDEA3170 Monotherapy in Subjects With Gout (NCT01927198) | Ardea Biosciences, Inc. | 2013-08-01 |
| Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder (NCT01904773) | AstraZeneca | 2013-08-01 |
| Drug Combination on Exercise Performance at High Altitude (NCT01902758) | University of Montana | 2013-08-01 |
| Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata (NCT01950780) | Columbia University | 2013-08-01 |
| Effect of Gastric Balloon in Morbid Obesity: Prospective Study (NCT02128165) | Mansoura University | 2013-08-01 |
| Effect of Intralymphatic Immunotherapy (NCT02255604) | University of Aarhus | 2013-08-01 |
| Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa (NCT01796197) | Dana-Farber Cancer Institute | 2013-08-01 |
| Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma (NCT01495988) | Melanoma Research Foundation Breakthrough Consortium | 2013-08-01 |
| Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation (NCT01929200) | Betta Pharmaceuticals Co., Ltd. | 2013-08-01 |
| Human Chorionic Gonadotrophin in an Antagonist Protocol (NCT01833858) | Cairo University | 2013-08-01 |
| Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients (NCT01921296) | Lynn Henry | 2013-08-01 |
| Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. (NCT01993784) | Peking University | 2013-08-01 |
| Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma (NCT01920191) | University Hospital, Geneva | 2013-08-01 |
| Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma (NCT01590160) | University College, London | 2013-08-01 |
| A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection (NCT01832259) | University of Utah | 2013-08-01 |
| S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma (NCT03668366) | Fudan University | 2013-08-01 |
| Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy (NCT01893125) | Convergence Pharmaceuticals | 2013-08-01 |
| Translational Neuroscience Optimization of GlyT1 Inhibitor (NCT01911676) | Yale University | 2013-08-01 |
| A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma (NCT02076646) | Philogen S.p.A. | 2013-07-31 |
| A Phase I/II Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02957019) | Philogen S.p.A. | 2013-07-31 |
| A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures (NCT01866111) | SK Life Science, Inc. | 2013-07-31 |
| Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery (NCT01835145) | National Cancer Institute (NCI) | 2013-07-31 |
| Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT01890265) | Kyntra Bio | 2013-07-30 |
| A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee (NCT01919164) | EMD Serono Research & Development Institute, Inc. | 2013-07-29 |
| Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion (NCT01901692) | Asan Medical Center | 2013-07-29 |
| Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer (NCT01873833) | University of Southern California | 2013-07-29 |
| Efficacy of Tocilizumab in Primary Sjögren's Syndrome. (NCT01782235) | University Hospital, Strasbourg, France | 2013-07-24 |
| Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations (NCT01861106) | National Cancer Institute (NCI) | 2013-07-24 |
| A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis (NCT01821248) | Kansai Hepatobiliary Oncology Group | 2013-07-23 |
| 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia (NCT01906489) | Akebia Therapeutics | 2013-07-23 |
| Anakinra for Inflammatory Pustular Skin Diseases (NCT01794117) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2013-07-22 |
| Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer (NCT01875250) | National Cancer Institute (NCI) | 2013-07-22 |
| A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia (NCT02038868) | Astellas Pharma Inc | 2013-07-22 |
| A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB) (NCT01859923) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-07-20 |
| The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (NCT00936819) | Ottawa Hospital Research Institute | 2013-07-19 |
| Amlexanox for Type 2 Diabetes and Obesity (NCT01842282) | University of Michigan | 2013-07-19 |
| Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome (NCT01893320) | M.D. Anderson Cancer Center | 2013-07-18 |
| A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT01790503) | Daiichi Sankyo | 2013-07-18 |
| Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers (NCT02046083) | University Hospital, Clermont-Ferrand | 2013-07-18 |
| Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) (NCT01888874) | Lakefront Biotherapeutics NV | 2013-07-17 |
| Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer (NCT01730833) | City of Hope Medical Center | 2013-07-17 |
| Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy (NCT01867710) | Janssen Pharmaceutica N.V., Belgium | 2013-07-16 |
| A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma (NCT01908777) | Memorial Sloan Kettering Cancer Center | 2013-07-16 |
| Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT01880567) | M.D. Anderson Cancer Center | 2013-07-15 |
| Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV (NCT01601626) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-07-13 |
| TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas (NCT01851369) | National Cancer Institute (NCI) | 2013-07-12 |
| Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease (NCT01734733) | Living Cell Technologies | 2013-07-12 |
| Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT01835223) | Roswell Park Cancer Institute | 2013-07-11 |
| Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC) (NCT01818986) | University of Texas Southwestern Medical Center | 2013-07-10 |
| Eosinophilic Esophagitis Clinical Therapy Comparison Trial (NCT01821898) | Baylor College of Medicine | 2013-07-09 |
| Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis (NCT01988103) | Amgen | 2013-07-09 |
| Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma (NCT01913691) | National Cancer Institute (NCI) | 2013-07-09 |
| CT Antigen TCR-redirected T Cells for Ovarian Cancer. (NCT01567891) | Adaptimmune | 2013-07-09 |
| Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy (NCT01869114) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-07-08 |
| Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer (NCT01835158) | National Cancer Institute (NCI) | 2013-07-08 |
| Therapy for Children With Advanced Stage Neuroblastoma (NCT01857934) | St. Jude Children's Research Hospital | 2013-07-05 |
| A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma (NCT01877005) | The Lymphoma Academic Research Organisation | 2013-07-04 |
| Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study (NCT01891318) | Case Comprehensive Cancer Center | 2013-07-03 |
| SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN (NCT02057107) | Heath Skinner | 2013-07-03 |
| Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT01832727) | Amgen | 2013-07-02 |
| Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (NCT01811940) | New York State Psychiatric Institute | 2013-07-01 |
| CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI) (NCT01905475) | Polyphor Ltd. | 2013-07-01 |
| Lipopeptide Immunisation With GTU-multiHIV Trial (NCT01492985) | ANRS, Emerging Infectious Diseases | 2013-07-01 |
| Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma (NCT01944982) | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 2013-07-01 |
| Children With Hemiparesis Arm and Hand Movement Project (CHAMP Study) (NCT01895660) | Virginia Polytechnic Institute and State University | 2013-07-01 |
| YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering (NCT01837823) | Icahn School of Medicine at Mount Sinai | 2013-07-01 |
| A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT01862224) | Janssen Research & Development, LLC | 2013-07-01 |
| Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan (NCT01896830) | Sanofi Pasteur, a Sanofi Company | 2013-07-01 |
| A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan (NCT01882868) | Sanofi | 2013-07-01 |
| Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients (NCT01897051) | Yonsei University | 2013-07-01 |
| A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy (NCT01904253) | Taiho Oncology, Inc. | 2013-07-01 |
| Alternative Treatment Paradigm for Natalizumab Trial (NCT01710228) | University of Texas Southwestern Medical Center | 2013-07-01 |
| Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia (NCT01912560) | Catabasis Pharmaceuticals | 2013-07-01 |
| An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction (NCT01900795) | Purdue Pharma LP | 2013-07-01 |
| HRZE Fasted/Fed in Newly Diagnosed TB (NCT02121314) | University Medical Center Groningen | 2013-07-01 |
| Efficacy of Premixed Nitrous Oxide and Oxygen in Elderly Patient With Out-of-hospital Severe Acute Pain (NCT01990404) | University Hospital, Toulouse | 2013-07-01 |
| AC105 in Patients With Acute Traumatic Spinal Cord Injury (NCT01750684) | Acorda Therapeutics | 2013-07-01 |
| Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke (NCT01910363) | University of Tokushima | 2013-07-01 |
| Study of Losartan in the Treatment of NAFLD in Children (NCT01913470) | Miriam Vos, MD | 2013-07-01 |
| CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma (NCT01746173) | Dana-Farber Cancer Institute | 2013-07-01 |
| Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) (NCT01903473) | University of Liege | 2013-07-01 |
| HOPE-Epilepsy Trial (NCT01744275) | Hospital do Coracao | 2013-07-01 |
| A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT01886469) | Ironshore Pharmaceuticals and Development, Inc | 2013-07-01 |
| The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension (NCT01996449) | University of Texas Southwestern Medical Center | 2013-07-01 |
| Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age (NCT01879540) | Novartis Vaccines | 2013-07-01 |
| Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure (NCT01858480) | RiboCor, Inc. | 2013-07-01 |
| A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis (NCT01906658) | Mallinckrodt | 2013-07-01 |
| Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. (NCT01777776) | Array BioPharma | 2013-07-01 |
| TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy (NCT02449902) | TherapeuticsMD | 2013-07-01 |
| The Effect Methylphenidate Hydrochloride on Pain and Auditory Sensitivity in Healthy Subjects (NCT01914822) | Rambam Health Care Campus | 2013-07-01 |
| Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (NCT01868997) | Amgen | 2013-07-01 |
| Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above (NCT01879553) | Novartis Vaccines | 2013-07-01 |
| Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold (NCT01958502) | Emdadi Kamyab Hospital | 2013-07-01 |
| Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients (NCT01894906) | Rockwell Medical Technologies, Inc. | 2013-07-01 |